Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
paper
Cited
Public
Unavailable
- Authors
- Rose, Jed E; Behm, Frédérique M; Drgon, Tomas; Johnson, Catherine; Uhl, George R
- Year
- 2010
- Journal
- Molecular medicine (Cambridge, Mass.)
- PMID
- 20379614
- DOI
- 10.2119/molmed.2009.00159
- PMCID
- PMC2896464
Improving and targeting nicotine replacement therapy (NRT) are cost-effective strategies for reducing adverse health consequences for smokers. Treatment studies document the efficacy of precessation NRT and support important roles for level of nicotine dependence and precessation smoking reduction in successful quitting. However, prior work has not identified the optimal precessation dose or means for personalizing NRT. Genome-wide association has identified groups of genomic markers associated with successful quitting, allowing us to develop a v1.0 "quit-success" genotype score. We now report influences of v1.0 quit-success genotype score, level of dependence and precessation smoking reduction in a smoking cessation trial that examined effects of 21 versus 42 mg/24 h precessation NRT. Four hundred seventy-nine smokers were randomized to 21 or 42 mg NRT, initiated 2 wks prior to target quit dates. We monitored self-reported abstinence and end-expired air carbon monoxide (CO). Genotyping used Affymetrix arrays (Santa Clara, CA, USA). The primary outcome was 10-wk continuous smoking abstinence. NRT dose, level of nicotine dependence and genotype scores displayed significant interactive effects on successful quitting. Successful abstinence also was predicted by CO reductions during precessation NRT. These results document ways in which smoking cessation strategies can be personalized based on levels of nicotine dependence, genotype scores and CO monitoring. These assessments, taken together, can help match most smokers with optimal NRT doses and help rapidly identify some who may be better treated using other methods.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Comprehensive Analysis Based on Genes Associated With Cuproptosis, Ferroptosis, and Pyroptosis for the Prediction of Diagnosis and Therapies in Coronary Artery Disease. | Zhang Y et al. | — | 2025 | → |
| Oral health effects of non-combustible nicotine products: protocol for a systematic review and network meta-analysis. | La Rosa GRM et al. | — | 2025 | → |
| Examining the Effect of Genes on Depression as Mediated by Smoking and Modified by Sex. | Voorhies K et al. | — | 2024 | → |
| Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial. | Davis JM et al. | — | 2023 | → |
| A scoping review of smoking cessation pharmacogenetic studies to advance future research across racial, ethnic, and ancestral populations. | Prom-Wormley EC et al. | — | 2023 | → |
| Cross-Sectional Gene-Smoking Interaction Analysis in Relation to Subclinical Atherosclerosis-Results From the IMPROVE Study. | Maitusong B et al. | — | 2023 | → |
| Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. | Theodoulou A et al. | — | 2023 | → |
| Genomic medicine to reduce tobacco and related disorders: Translation to precision prevention and treatment. | Chen LS et al. | — | 2023 | → |
| The Effects of Scheduled Smoking Reduction and Precessation Nicotine Replacement Therapy on Smoking Cessation: Randomized Controlled Trial With Compliance. | Cinciripini PM et al. | — | 2023 | → |
| Effect of Electronic Portal Messaging With Embedded Asynchronous Care on Physician-Assisted Smoking Cessation Attempts: A Randomized Clinical Trial. | Erdmann M et al. | — | 2022 | → |
| The associations between the credibility of the tobacco control regulatory body and smoking behavior change among Saudi smokers. | Alanazi AM et al. | — | 2022 | → |
| An exploration of associations between smoking motives and behavior as a function of body mass index. | Ely AV et al. | — | 2021 | → |
| HCP5, as the sponge of miR-1291, facilitates AML cell proliferation and restrains apoptosis via increasing PIK3R5 expression. | Liu Y et al. | — | 2021 | → |
| Whole-Exome Sequencing to Identify Potential Genetic Risk in Substance Use Disorders: A Pilot Feasibility Study. | AshaRani PV et al. | — | 2021 | → |
| A logical relationship for schizophrenia, bipolar, and major depressive disorder. Part 1: Evidence from chromosome 1 high density association screen. | Zhang Z et al. | — | 2020 | → |
| Etiopathogenetic Mechanisms in Diverticular Disease of the Colon. | Camilleri M et al. | — | 2020 | → |
| Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial. | Chen LS et al. | — | 2020 | → |
| LncRNA ROR1‑AS1 high expression and its prognostic significance in liver cancer. | Zhang Z et al. | — | 2020 | → |
| Mixed-model admixture mapping identifies smoking-dependent loci of lung function in African Americans. | Ziyatdinov A et al. | — | 2020 | → |
| Personalized dosing of nicotine replacement therapy versus standard dosing for the treatment of individuals with tobacco dependence: study protocol for a randomized placebo-controlled trial. | Zawertailo L et al. | — | 2020 | → |
| The Lung Adenocarcinoma Microenvironment Mining and Its Prognostic Merit. | Zhao R et al. | — | 2020 | → |
| Whole-transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1-MET fusion-negative secondary glioblastoma multiforme. | Chen BS et al. | — | 2020 | → |
| A Gene-Environment Interaction Between Smoking and Gene polymorphisms Provides a High Risk of Two Subgroups of Sarcoidosis. | Rivera NV et al. | — | 2019 | → |
| A logical relationship for schizophrenia, bipolar, and major depressive disorder. Part 4: Evidence from chromosome 4 high-density association screen. | Tang J et al. | — | 2019 | → |
| Determining population stratification and subgroup effects in association studies of rare genetic variants for nicotine dependence. | Hsieh AR et al. | — | 2019 | → |
| Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. | Lindson N et al. | — | 2019 | → |
| Differential Gene Expression in Erlotinib-Treated Fibroblasts. | Wickersham KE et al. | — | 2019 | → |
| Low lncRNA ZNF385D‑AS2 expression and its prognostic significance in liver cancer. | Zhang Z et al. | — | 2019 | → |
| Smoking reduction interventions for smoking cessation. | Lindson N et al. | — | 2019 | → |
| A novel relationship for schizophrenia, bipolar and major depressive disorder Part 3: Evidence from chromosome 3 high density association screen. | Chen X et al. | — | 2018 | → |
| Disease networks identify specific conditions and pleiotropy influencing multimorbidity in the general population. | Amell A et al. | — | 2018 | → |
| From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation. | Salloum NC et al. | — | 2018 | → |
| Kids Safe and Smokefree (KiSS) Multilevel Intervention to Reduce Child Tobacco Smoke Exposure: Long-Term Results of a Randomized Controlled Trial. | Lepore SJ et al. | — | 2018 | → |
| Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How. | Chen LS et al. | — | 2018 | → |
| Nicotine preloading for smoking cessation: the Preloading RCT. | Aveyard P et al. | — | 2018 | → |
| Pathways to precision medicine in smoking cessation treatments. | Chen LS et al. | — | 2018 | → |
| Polygenic Score × Intervention Moderation: an Application of Discrete-Time Survival Analysis to Model the Timing of First Marijuana Use Among Urban Youth. | Musci RJ et al. | — | 2018 | → |
| Precision Psychiatry and Dual Disorders. | Szerman N et al. | — | 2018 | → |
| Bivariate genome-wide association analyses identified genetic pleiotropic effects for bone mineral density and alcohol drinking in Caucasians. | Lu S et al. | — | 2017 | → |
| Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits. | Justice AE et al. | — | 2017 | → |
| Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer. | Shivakumar M et al. | — | 2017 | → |
| Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. | Schuit E et al. | — | 2017 | → |
| Role of LRRTMs in synapse development and plasticity. | Roppongi RT et al. | — | 2017 | → |
| Does cigarette reduction while using nicotine replacement therapy prior to a quit attempt predict abstinence following quit date? | Lindson-Hawley N et al. | — | 2016 | → |
| Expression and characterization of transmembrane and coiled-coil domain family 3. | Sohn WJ et al. | — | 2016 | → |
| Genetic Loci and Novel Discrimination Measures Associated with Blood Pressure Variation in African Americans Living in Tallahassee. | Quinlan J et al. | — | 2016 | → |
| Passenger mutations and aberrant gene expression in congenic tissue plasminogen activator-deficient mouse strains. | Szabo R et al. | — | 2016 | → |
| Smokescreen: a targeted genotyping array for addiction research. | Baurley JW et al. | — | 2016 | → |
| The association of dopamine pathway gene score, nicotine dependence and smoking cessation in a rural male population of Shandong, China. | Li S et al. | — | 2016 | → |
| Validity of using ad hoc methods to analyze secondary traits in case-control association studies. | Yung G et al. | — | 2016 | → |
| A preliminary exploration of college smokers' reactions to nicotine dependence genetic susceptibility feedback. | Lipkus IM et al. | — | 2015 | → |
| Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date. | Mamoun M et al. | — | 2015 | → |
| Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation. | Chen LS et al. | — | 2015 | → |
| Polygenic score × intervention moderation: an application of discrete-time survival analysis to modeling the timing of first tobacco use among urban youth. | Musci RJ et al. | — | 2015 | → |
| Smoking-Associated Site-Specific Differential Methylation in Buccal Mucosa in the COPDGene Study. | Wan ES et al. | — | 2015 | → |
| ALDH2 is associated to alcohol dependence and is the major genetic determinant of "daily maximum drinks" in a GWAS study of an isolated rural Chinese sample. | Quillen EE et al. | — | 2014 | → |
| An exploratory examination of the mechanisms through which pre-quit patch use aids smoking cessation. | Schüz N et al. | — | 2014 | → |
| A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens. | Liu YZ et al. | — | 2014 | → |
| Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data. | Tang H et al. | — | 2014 | → |
| Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm. | Rose JE et al. | — | 2014 | → |
| Curious cases: Altered dose-response relationships in addiction genetics. | Uhl GR et al. | — | 2014 | → |
| Fine mapping on chromosome 13q32-34 and brain expression analysis implicates MYO16 in schizophrenia. | Rodriguez-Murillo L et al. | — | 2014 | → |
| Genome-wide analyses of borderline personality features. | Lubke GH et al. | — | 2014 | → |
| Genome-wide interrogation of longitudinal FEV1 in children with asthma. | Wu K et al. | — | 2014 | → |
| Genome-wide linkage and regional association study of obesity-related phenotypes: the GenSalt study. | Liu AY et al. | — | 2014 | → |
| Interplay of genetic risk (CHRNA5) and environmental risk (partner smoking) on cigarette smoking reduction. | Chen LS et al. | — | 2014 | → |
| Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome. | Leventhal AM et al. | — | 2014 | → |
| Novel genetic variants modify the effect of smoking on carotid plaque burden in Hispanics. | Della-Morte D et al. | — | 2014 | → |
| Smoking cessation in men and women. | Potter AS | — | 2014 | → |
| Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances. | Uhl GR et al. | — | 2014 | → |
| Adapting smoking cessation treatment according to initial response to precessation nicotine patch. | Rose JE et al. | — | 2013 | → |
| Biomarkers for smoking cessation. | Bough KJ et al. | — | 2013 | → |
| Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature. | Carpenter MJ et al. | — | 2013 | → |
| Complex patterns of genomic admixture within southern Africa. | Petersen DC et al. | — | 2013 | → |
| Effectiveness of individual and group counseling for cessation of tobacco habit amongst industrial workers in pimpri, pune--an interventional study. | Savant SC et al. | — | 2013 | → |
| Genetic network and gene set enrichment analysis to identify biomarkers related to cigarette smoking and lung cancer. | Fang X et al. | — | 2013 | → |
| Genetics in population health science: strategies and opportunities. | Belsky DW et al. | — | 2013 | → |
| Genome-wide association analysis for multiple continuous secondary phenotypes. | Schifano ED et al. | — | 2013 | → |
| Genome-wide association study of obsessive-compulsive disorder. | Stewart SE et al. | — | 2013 | → |
| Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? | Hall FS et al. | — | 2013 | → |
| Kids Safe and Smokefree (KiSS): a randomized controlled trial of a multilevel intervention to reduce secondhand tobacco smoke exposure in children. | Lepore SJ et al. | — | 2013 | → |
| Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. | Bergen AW et al. | — | 2013 | → |
| Novel susceptibility genes associated with diabetic cataract in a Taiwanese population. | Lin HJ et al. | — | 2013 | → |
| Role of genomics on the path to personalized medicine. | Tremblay J et al. | — | 2013 | → |
| The future of Connected Health in preventive medicine. | Agboola SO et al. | — | 2013 | → |
| What do Differences in Emotional Regulation in Individuals Addicted to Different Substances Tell us About Addiction Treatment? | Scott Hall F | — | 2013 | → |
| A multiscale and multiparametric approach for modeling the progression of oral cancer. | Exarchos KP et al. | — | 2012 | → |
| A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia. | Wing VC et al. | — | 2012 | → |
| Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. | Wan ES et al. | — | 2012 | → |
| Clinico-epidemiological profile of tobacco users attending a tobacco cessation clinic in a teaching hospital in Bangalore city. | D'Souza G et al. | — | 2012 | → |
| Genome-wide association study of comorbid depressive syndrome and alcohol dependence. | Edwards AC et al. | — | 2012 | → |
| Genotype×age interaction in human transcriptional ageing. | Kent JW et al. | — | 2012 | → |
| Mouse models for studying genetic influences on factors determining smoking cessation success in humans. | Hall FS et al. | — | 2012 | → |
| Nicotine replacement therapy for smoking cessation. | Stead LF et al. | — | 2012 | → |
| Oral Nicotine Self-Administration in Rodents. | Collins AC et al. | — | 2012 | → |
| The genetics of addiction-a translational perspective. | Agrawal A et al. | — | 2012 | → |
| Individualized smoking cessation treatment: roles for sets of genomic markers. | Uhl GR et al. | — | 2011 | → |
| Menthol preference among smokers: association with TRPA1 variants. | Uhl GR et al. | — | 2011 | → |
| Nicotine preloading: the importance of a pre-cessation reduction in smoking behavior. | Rose JE | — | 2011 | → |
| Response to Rose (2011): nicotine preloading: the importance of a pre-cessation reduction in smoking behavior. | Lindson N et al. | — | 2011 | → |
| Smoking behavior and delivery of evidence-based care for veterans with spinal cord injuries and disorders. | Weaver FM et al. | — | 2011 | → |
| Genome-wide association for smoking cessation success in a trial of precessation nicotine replacement. | Uhl GR et al. | — | 2010 | → |